Dengue Virus is Hyperendemic in Nigeria from 2009 to 2020: A Contemporary Systematic Review
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Backround: Data on Dengue virus (DENV) infection prevalence, geographic distribution and risk factors are necessary to direct appropriate utilization of existing and emerging control strategies. This study aimed to determine the pooled prevalence, risk factors of DENV infection and the circulating serotypes within Nigeria from January 1, 2009 to December 31, 2020. Materials and methods: Twenty-one studies out of 2,215 available articles were eligible and included for this systematic review. Relevant articles were searched, screened and included in this study according to the Preferred Reporting Items for Systematic reviews and MetaAnalyses (PRISMA) criteria. The risk of bias in primary studies was assessed by Cochrane's method. Heterogeneity of pooled prevalence was calculated using the chi-square test on Cochrane's Q statistic, which was quantified by I-square values. The random-effects analyses of proportions were used to determine the pooled prevalence of DENV antibodies, antigen and RNA from eligible studies. Results: Of these, 3 studies reported co-circulation of all the 4 serotypes, while 2 separately reported co-circulation of DENV-1 &2 and DENV-1 to -3. All the antibody-based studies had significantly high heterogeneity (I2 >90%, P <0.05), while the NS1 and PCR-based studies had low heterogeneity (I2 <25%, P >0.05). The pooled prevalence of DENV IgM, IgG, RNA, NS1 and neutralizing antibodies were 16.8%, 34.7%, 7.7%, 7.7% and 0.7%, respectively. Southeast Nigeria had the highest pooled DENV-IgG seropositivity, 77.1%. Marital status, gender, educational level and occupation status, the proximity of residence to refuse dumpsite, frequent use of trousers and long sleeve shirts were significantly associated with DENV IgG seropositivity (P <0.05). Conclusion: Based on these findings, it can be inferred that Nigeria is hyperendemic for Dengue fever and needs concerted efforts to control its spread within and outside the country.
Abstract
Backround: Data on Dengue virus (DENV) infection prevalence, geographic distribution and risk factors are necessary to direct appropriate utilization of existing and emerging control strategies. This study aimed to determine the pooled prevalence, risk factors of DENV infection and the circulating serotypes within Nigeria from January 1, 2009 to December 31, 2020. Materials and methods: Twenty-one studies out of 2,215 available articles were eligible and included for this systematic review. Relevant articles were searched, screened and included in this study according to the Preferred Reporting Items for Systematic reviews and MetaAnalyses (PRISMA) criteria. The risk of bias in primary studies was assessed by Cochrane's method. Heterogeneity of pooled prevalence was calculated using the chi-square test on Cochrane's Q statistic, which was quantified by I-square values. The random-effects analyses of proportions were used to determine the pooled prevalence of DENV antibodies, antigen and RNA from eligible studies. Results: Of these, 3 studies reported co-circulation of all the 4 serotypes, while 2 separately reported co-circulation of DENV-1 &2 and DENV-1 to -3. All the antibody-based studies had significantly high heterogeneity (I2 >90%, P <0.05), while the NS1 and PCR-based studies had low heterogeneity (I2 <25%, P >0.05). The pooled prevalence of DENV IgM, IgG, RNA, NS1 and neutralizing antibodies were 16.8%, 34.7%, 7.7%, 7.7% and 0.7%, respectively. Southeast Nigeria had the highest pooled DENV-IgG seropositivity, 77.1%. Marital status, gender, educational level and occupation status, the proximity of residence to refuse dumpsite, frequent use of trousers and long sleeve shirts were significantly associated with DENV IgG seropositivity (P <0.05). Conclusion: Based on these findings, it can be inferred that Nigeria is hyperendemic for Dengue fever and needs concerted efforts to control its spread within and outside the country.
참고문헌 (40)
- Powell JR, "Mosquito-borne human viral diseases: Why Aedes aegypti?", Am J Trop Med Hyg, 98, pp.1563~1565 (2018)
- Katzelnick LC, "Dengue viruses cluster antigenically but not as discrete serotypes", Science, 349, pp.1338~1343 (2015)
- Reich NG, "Interactions between serotypes of dengue highlight epidemiological impact of crossimmunity", J R Soc Interface, 10, pp.20130414~ (2013)
- "Dengue and severe dengue"[URL]
- Kuno G, "A re-examination of the history of etiologic confusion between Dengue and Chikungunya", PLoS Negl Trop Dis, 9, pp.e0004101~ (2015)
- Simo FBN, "Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies", Sci Rep, 9, pp.13626~ (2019)
- Humphrey JM, "Dengue in the Middle East and North Africa: a systematic review", PLoS Negl Trop Dis, 10, pp.e0005194~ (2016)
- Otu AA, "A cross-sectional survey on the seroprevalence of dengue fever in febrile patients attending health facilities in Cross River State, Nigeria", PLoS One, 14, pp.e0215143~ (2019)
- Otu A, "Dengue fever - an update review and implications for Nigeria, and similar countries", Afr Health Sci, 19, pp.2000~2007 (2019)
- Amarasinghe A, "Dengue virus infection in Africa", Emerg Infect Dis, 17, pp.1349~1354 (2011)
- Nasir IA, "Dengue virus non-structural Protein-1 expression and associated risk factors among febrile Patients attending University of Abuja Teaching Hospital, Nigeria", Virus Res, 230, pp.7~12 (2017)
- Rather IA, "Prevention and control strategies to counter dengue virus infection", Front Cell Infect Microbiol, 7, pp.336~ (2017)
- Liebman KA, "Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003)", PLoS Negl Trop Dis, 6, pp.e1472~ (2012)
- Hatcher EL, "Virus Variation Resource - improved response to emergent viral outbreaks", Nucleic Acids Res, 45, pp.D482~D490 (2017)
- Mustapha JO, "Survey of malaria and anti-dengue virus IgG among febrile HIVinfected patients attending a tertiary hospital in Abuja, Nigeria", HIV AIDS (Auckl), 9, pp.145~151 (2017)
- Kingsley UB, "Dengue Virus Antibodies in Patients Presenting with Pyrexia attending Jos University Teaching Hospital, Jos, Nigeria", Saudi J Pathol Microbiol, 3, pp.47~55 (2018)
- Sule WF, "Probable primary and secondary dengue viral infections and associated host factors among university undergraduates in Osun State, Nigeria", Alexandria J Med, 55, pp.25~30 (2019)
- Idoko MO, "Prevalence of Dengue virus and Malaria in patients with Febrile complaints in Kaduna Metropolis, Nigeria", Br Microbiol Res J, 8, pp.343~347 (2015)
- Oladipo EK, "Detectable anti-dengue virus IgM antibodies among healthy individuals in Ogbomoso, Oyo State, Nigeria", Am J Infect Dis, 10, pp.64~67 (2014)
- uchi NK, "Parallel and concurrent infection of Dengue virus and Plasmodium falciparum among patients with febrile illnesses attending Bingham University Health Centre, Karu, Nigeria", Int J Trop Dis Health, 41, pp.45~51 (2020)
- Mahmoud MA, "Dengue virus immunoglobulinaemia among pregnant women and blood donors in Nigeria: need for integration into disease management policy", J Health Commun, 3, pp.40~ (2018)
- Oladipo EK, "Yellow fever, Dengue fever and West Nile viruses co-circulation in Ogbomoso", IJMDC, 2, pp.50~54 (2018)
- Kolawole OM, "Dengue virus and malaria concurrent infection among febrile subjects within Ilorin metropolis, Nigeria", J Med Viro, 89, pp.1347~1353 (2017)
- Dawurung JS, "Serological evidence of acute dengue virus infection among febrile patients attending Plateau State Specialist Hospital Jos, Nigeria", Rep Opinion, 2, pp.71~76 (2010)
- Onoja AB, "Co-circulation of dengue virus 1 and 2 several years after single serotype detection in Cross River State, Nigeria", Sokoto J Vet Sci, 18, pp.167~170 (2020)
- Hamisu TM, "Prevalence of Dengue virus infection among febrile outpatients attending University of Maiduguri Teaching Hospital in Borno State, Nigeria", IOSR-JDMS, 16, pp.155~159 (2017)
- Baba M, "Dengue virus infections in patients suspected of malaria", typhoid in Nigeria, 2009, pp.5, 129~134
- Adesina OA, "Incidence of Dengue virus infections in febrile episodes in Ile-Ife, Nigeria", Afr J Infect Dis, 10, pp.21~24 (2016)
- Abdulaziz MM, "Prevalence and factors associated with dengue fever among febrile patients attending secondary health facilities in Kano metropolis, Nigeria", Afr J Clin Exp Microbiol, 21, pp.340~348 (2020)
- Chukwuma GO, "Seroprevalence of dengue virus among children with febrile illness in Nnewi, Nigeria", J Med Res, 4, pp.24~30 (2018)
- Onyedibe K, "A cross sectional study of dengue virus infection in febrile patients presumptively diagnosed of malaria in Maiduguri and Jos plateau, Nigeria", Malawi Med J, 30, pp.276~282 (2018)
- Ahmed A, "Dengue fever in the Darfur Area, Western Sudan", Emerg Infect Dis, 25, pp.2126~ (2019)
- Oyero OG, "High dengue NS1 antigenemia in febrile patients in Ibadan, Nigeria", Virus Res, 191, pp.59~61 (2014)
- Ayolabi CI, "Detection of Dengue viruses among febrile patients in Lagos, Nigeria and phylogenetics of circulating Dengue serotypes in Africa", Infect Genet Evol, 75, pp.103947~ (2019)
- Lutomiah J, "Dengue Outbreak in Mombasa City, Kenya, 2013-2014: Entomologic Investigations", PLoS Negl Trop Dis, 10, pp.e0004981~ (2016)
- Althouse BM, "Impact of climate and mosquito vector abundance on sylvatic arbovirus circulation dynamics in Senegal", Am J Trop Med Hyg, 92, pp.88~97 (2015)
- Oderinde BS, "Prevalence of locally undetected acute infections of Flaviviruses in North-Eastern Nigeria", Virus Res, 286, pp.198060~ (2020)
- Elduma AH, "High seroprevalence of Dengue virus infection in Sudan: systematic review and meta-analysis", Trop Med Infect Dis, 5, pp.120~ (2020)
- Young KI, "Abundance and distribution of sylvatic dengue virus vectors in three different land cover types in Sarawak, Malaysian Borneo", Parasit Vectors, 10, pp.406~ (2017)
- Simo FBN, "Dengue virus infection in people residing in Africa: a systematic review and meta-analysis of prevalence studies", Sci Rep, 9, pp.13626~ (2019)